6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide
C9H11BrN4O — CID 134714782
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide
6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide (PubChem CID 134714782) has the molecular formula C9H11BrN4O and a molecular weight of 271.12 g/mol. Its IUPAC name is 6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 134714782 |
| Molecular Formula | C9H11BrN4O |
| Molecular Weight | 271.12 g/mol |
| Exact Mass | 270.01 |
| IUPAC Name | 6-bromo-N-[(E)-dimethylaminomethylideneamino]pyridine-2-carboxamide |
| SMILES | CN(C)/C=N/NC(=O)c1cccc(Br)n1 |
| InChI | InChI=1S/C9H11BrN4O/c1-14(2)6-11-13-9(15)7-4-3-5-8(10)12-7/h3-6H,1-2H3,(H,13,15)/b11-6+ |
| InChIKey | ZECIQTNFCLSJLP-IZZDOVSWSA-N |
| XLogP | 1.08 |
| TPSA | 57.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 15 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 271.12 |
| LogP ≤ 5 | 1.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134714782 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.